ArticleJournal of experimental & clinical cancer research : CR2015

Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.

Sabine Heublein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.